BRIEF-Halozyme announces initiation of clinical trial collaboration By: Reuters: Company News July 13, 2017 at 08:57 AM EDT * Initiation of clinical trial collaboration evaluating Halozyme's pegph20 in combination with anti-PDL1 immunotherapy Read More >> Related Stocks: Halozyme Therapeutic